首页> 外文期刊>Journal of Analytical Atomic Spectrometry >An insight into the determination of size and number concentration of silver nanoparticles in blood using single particle ICP-MS (splCP-MS): feasibility of application to samples relevant to in vivo toxicology studies
【24h】

An insight into the determination of size and number concentration of silver nanoparticles in blood using single particle ICP-MS (splCP-MS): feasibility of application to samples relevant to in vivo toxicology studies

机译:使用单粒子ICP-MS(SPLCP-MS)介绍血液中银纳米颗粒的尺寸和数量浓度的探讨:应用于与体内毒理学研究相关的样品的可行性

获取原文
获取原文并翻译 | 示例
           

摘要

Toxicological studies concerning nanomaterials in complex biological matrices usually require a carefully designed workflow that involves handling, transportation and preparation of a large number of samples without affecting the nanoparticle (NP) characteristics, as well as measurement methods that enable their reliable characterisation. This work describes method development for the determination of number concentration and size of silver nanoparticles (AgNP) in blood for the purpose of application to the typical workflow of an in vivo toxicology assessment involving blood-containing AgNP and Ag(I) leached out from medical devices. A systematic comparison of single particle detection using millisecond versus microsecond dwell times in the presence of different ionic Ag [Ag(I)]-to-AgNP ratios by splCP-MS was undertaken to achieve sufficient selectivity for the determination of NP number concentration. This was achieved for the first time in a complex media such as 2.5% tetramethylammonium hydroxide (TMAH)/0.1% Triton X-100 (v/v) diluent, which was proven to preserve nanoparticle stability upon 8 days of storage following AgNP quantitative extraction from the blood matrix. The potential of microsecond dwell time for improved discrimination of AgNP (40 nm) from Ag(I) was demonstrated for ionic to nanoparticle ratios [Ag(I)/AgNP] of up to 106-fold. For NP sizing, a systematic study of the impact of matrix-matched ionic calibration on the derived particle size by splCP-MS is also described. Three different ionic calibration media including 1% HNO_3 (v/v), 1 mM trisodium citrate and 2.5% TMAH/0.1% Triton X-100 (v/v) were tested. Student f-test evidenced statistically significant differences between the slope of the calibration curve of Ag(I) in TMAH/Triton X-100 compared to HNO_3 and trisodium citrate matrices, whereas no significant differences were found between the two latter media. Moreover, a good agreement was found between the particle diameter derived from splCP-MS following ionic calibration in TMAH/Triton X-100 and the diameter obtained with transmission electron microscopy (TEM), demonstrating the importance of matrix-matched calibration for NP size determination in a complex matrix using splCP-MS. Number concentration recovery measurements on blood samples spiked with AgNP and size measurements both using splCP-MS demonstrated the feasibility of the methodology developed here for potential future application to AgNP characterisation in toxicology research.
机译:关于复杂生物学基质中的纳米材料的毒理学研究通常需要精心设计的工作流程,该工作流程涉及处理,运输和制备大量样品,而不会影响纳米颗粒(NP)特性,以及能够可靠表征的测量方法。本作品描述了用于测定血液中银纳米粒子(AgNP)的数量浓度和大小的方法开发,以应用于涉及含有血液的AgNP和Ag(i)从医疗中渗出的体内毒理学评估的典型工作流程设备。通过SPLCP-MS在存在不同离子Ag [Ag(I)] - 至-GNP比例的情况下使用毫秒与微秒停留时间进行单颗粒检测的系统比较,以实现足够的选择性NP数浓度。这是第一次在复合介质中实现的,例如2.5%四甲基氢氧化铵(TMAH)/ 0.1%TRITON X-100(V / V)稀释剂,其被证明在AgNP定量萃取后8天的储存后保持纳米颗粒稳定性从血液基质。对来自Ag(I)的改善AgNP(40nm)判断的微秒停留时间的电位用于离子至纳米颗粒比[Ag(I)/ AgNP]高达106倍。对于NP尺寸,还描述了SPLCP-MS对衍生粒度对衍生粒度的影响的系统研究。测试包括1%HNO_3(v / v),1mM三柠檬酸钠和2.5%Tmah / 0.1%Triton X-100(v / v)的三种不同的离子校准介质。与HNO_3和柠檬酸三钠基质相比,学生F检验证明了TMAH / TRITON X-100中Ag(I)的校准曲线斜率之间的统计学显着差异,而两种后一种介质之间没有发现显着差异。此外,在TMAH / TRITON X-100中的离子校准之后衍生自SPLCP-MS的粒径与用透射电子显微镜(TEM)获得的直径之间的粒径均已达到良好的协议,证明了矩阵匹配校准对NP尺寸测定的重要性在使用SPLCP-MS的复杂矩阵中。使用SPLCP-MS的AGNP和尺寸测量掺入的血液样品的数量浓度恢复测量证明了该方法在此开发的方法,以便潜在的未来应用于毒理学研究中的AGNP表征。

著录项

  • 来源
    《Journal of Analytical Atomic Spectrometry》 |2021年第6期|1180-1192|共13页
  • 作者单位

    LGC Queens Road Teddington Middlesex TW11 OLY UK.;

    University of Zaragoza Aragón Institute of Engineering Research (I3A) Department of Analytical Chemistry Pedro Cerbuna 12 50009 Zaragoza Spain;

    LGC Queens Road Teddington Middlesex TW11 OLY UK.;

    LGC Queens Road Teddington Middlesex TW11 OLY UK.;

    Department of Analytical Chemistry Faculty of Chemistry Complutense University of Madrid (UCM) Av. Complutense s/n Madrid 28040 Spain;

    Department of Analytical Chemistry Faculty of Chemistry Complutense University of Madrid (UCM) Av. Complutense s/n Madrid 28040 Spain;

    University of Zaragoza Aragón Institute of Engineering Research (I3A) Department of Analytical Chemistry Pedro Cerbuna 12 50009 Zaragoza Spain Centro Universitario de la Defensa de Zaragoza Academia General Militar de Zaragoza Carretera de Huesca s/n 50090 Zaragoza Spain;

    University of Zaragoza Aragón Institute of Engineering Research (I3A) Department of Analytical Chemistry Pedro Cerbuna 12 50009 Zaragoza Spain;

    LGC Queens Road Teddington Middlesex TW11 OLY UK.;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号